Company intelligence / Profile preview

Edifice Health

San Mateo, California, United Statesedificehealth.com ↗

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

Edifice Health has developed the Inflammatory Age® test based on the Stanford 1,000 Immunomes research. This test quantifies Systemic Chronic Inflammation (SCI) and Immune Health, providing a metric to measure how much older or younger one's immune health appears compared to chronological age. The company has also identified over 150 actionable health interventions to reduce systemic chronic inflammation.

Therapeutic areas: OncologyWomen's HealthImmunologyOtherPsychiatryCardiovascularNeurologyInfectious Diseases
Modalities: Personalized nutritionsupplements
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborations with "big pharma, food companies and academic research groups"

Beyond the preview

Go deeper on Edifice Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Edifice Health.

Explore the full profile